Constarium
← Search

Table · dataset · 2026

Dual-Selector Biphasic Recognition Chiral Extraction for Naproxen Enantiomers: Experimental Evaluation and Molecular-Level Mechanism

Listed in ZivaHub

A dual-selector biphasic recognition chiral extraction (BRCE) system was developed for the resolution of racemic naproxen using hydrophobic l-di-<i>p</i>-toluoyl-d-tartaric acid (L-DTTA) in the organic phase and hydrophilic hydroxyethyl-β-cyclodextrin (HE-β-CD) in the aqueous phase.

Description

Single-selector screening first identified HE-β-CD as the preferred aqueous selector for <i>S</i>-naproxen and L-DTTA as a complementary organic selector for <i>R</i>-naproxen.

After optimization of selector concentrations, feed concentration, pH and temperature, the single-stage enantioselectivity yields 2.10, with an enantiomeric excess of 31.93%. Quantum chemical calculations and molecular dynamics simulations were then used to interpret the experimentally verified selectivity trends. The results indicate that HE-β-CD preferentially stabilizes <i>S</i>-naproxen through cavity-size matching and a directional hydrogen-bonding network near the modified cavity entrance, whereas L-DTTA favors <i>R</i>-naproxen through steric complementarity and extensive van der Waals contacts.

Read the rest (1 more)

The opposite recognition preferences of the two selectors generate a cooperative thermodynamic driving force across the oil/water interface. This experimentally validated mechanism provides criteria for selecting dual-phase chiral selectors and designing intensified liquid–liquid extraction systems for enantiomeric separations.

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 1 source records, 17 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3402107210 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancermapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Cancer']
concepts[field].anzsrc:field:320211mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Infectious Diseases']
concepts[field].anzsrc:group:3104mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Evolutionary Biology']
concepts[field].anzsrc:group:3108mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Plant Biology']
concepts[field].anzsrc:group:3204mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Immunology']
concepts[field].anzsrc:group:3402mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Inorganic Chemistry']
concepts[field].local:field:astronomymapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:chemistrymapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:life-sciencesmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:medicine-healthmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:physicsmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
licensesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/rights
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title